Onconetix
ONCO
10 hedge funds and large institutions have $26.7K invested in Onconetix in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
11% more funds holding
Funds holding: 9 → 10 (+1)
0% less ownership
Funds ownership: 0% → 0% (-0%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
89% less capital invested
Capital invested by funds: $242K → $26.7K (-$215K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$58.3K |
| 2 |
SRL
Scientech Research LLC
Jersey City,
New Jersey
|
+$12K |
| 3 |
VF
Virtu Financial
New York
|
+$8.58K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$5.15K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$5.15K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Zurich Cantonal Bank
Zurich,
Switzerland
|
-$77.2K |
| 2 |
Millennium Management
New York
|
-$24.9K |
| 3 |
SS
SBI Securities
Tokyo,
Japan
|
-$6.86K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6.46K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.72K |
ONCO Hedge Fund Activity: Q1 2025 in Review
10 of the 7,469 institutional investors tracked by Wall St. Rank reported a position in Onconetix (ONCO) for Q1 2025, worth a combined $26.7K — down 89% from $242K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ONCO positions and 3 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $58.3K. The largest seller was Zurich Cantonal Bank, cutting an estimated $77.2K.
- 10 institutional investors held Onconetix (ONCO) as of Q1 2025, up from 9 in Q4 2024.
- Funds reported $26.7K of Onconetix stock for Q1 2025, down 89% quarter-over-quarter.
- 4 funds opened new Onconetix positions in Q1 2025 and 3 closed out, a net change of +1 holder.
- The largest Onconetix buyer in Q1 2025 was HRT Financial, an estimated $58.3K added.
- The largest Onconetix seller in Q1 2025 was Zurich Cantonal Bank, an estimated $77.2K sold.
Based on aggregated 13F filings for Q1 2025.